Moss Adams Wealth Advisors LLC Immix Biopharma, Inc. Transaction History

Moss Adams Wealth Advisors LLC

  • $1.28 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 20, 2023
SELL
$1.6 - $2.9 $124 - $226
-78 Reduced 0.39%
20,000 $53.8 Million
Q1 2023

Dec 20, 2023
BUY
$1.72 - $3.14 $134 - $244
78 Added 0.39%
20,078 $36.5 Million
Q4 2022

Dec 20, 2023
BUY
$0.75 - $2.43 $15,000 - $48,600
20,000 New
20,000 $45.8 Million

About Immix Biopharma, Inc.

IMMX Quotes by TradingView
  • Ticker IMMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,910,100
  • Market Cap $58.6M
  • Description
  • Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...
More about IMMX
Track This Portfolio

Track Moss Adams Wealth Advisors LLC Portfolio

Follow Moss Adams Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moss Adams Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moss Adams Wealth Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email